First-authored PUBLICATIONS:

  • Osei-Sarfo K and Gudas LJ. Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells. PLoS One. 2019; 14(4)e0215234.

  • Osei-Sarfo K, Urvalek AM, Tang XH, Scognamiglio T, Gudas LJ. Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxdie and alcohol carcinogenesis model. Oncotarget. 2015; 6(8): 6040-6052.

  • Osei-Sarfo K, Gudas LJ. Retinoic acid suppresses the canonical Wnt signaling pathway in embryonic stem cells and activates the noncanonical Wnt signaling pathway. Stem Cells. 2014; 32: 2061-2071.

  • Osei-Sarfo K, Tang XH, Urvalek AM, Scognamiglio T, Gudas LJ. The molecular features of tongue epithelium treated with the carcinogen, 4-nitroquinoline-1-oxide, and alcohol as a model for HNSCC. Carcinogenesis. 2013; 34(11): 2673-2681.

  • Osei-Sarfo K, Castro I, Pellicer A. p15INK4b plays a crucial role in murine lymphoid development and tumorigenesis. Carcinogenesis. 2012; 33(3): 708-713.

  • Osei-Sarfo K, Martello L, Ibrahim S, Pellicer A. The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral. Oncogene. 2011; 30(34):3661-3671.

  • Osei-Sarfo K. Producing soluble His-tagged and GST-tagged RalGDS (Ral Guanine Nucleotide Dissociation Stimulator)-Related (Rgr) fusion proteins with Stratagene’s ArticExpressTM competent cells. Stratagene: Technical Note 2007.

CO-authored PUBLICATIONS:

  • Malkovskiy AV, Van Wassenhove LD, Goltsev Y, Osei-Sarfo K, Chen CH, Efron B, Gudas LJ, Mochly-Rosen D, and Rajadas J. The Effect of ethanol consumption on composition and morphology of femur cortical bone in wild-type and ALDH2*2-homozygous mice. Calcified Tissue International. 2021; 108(8):265-276.

  • Norman D, Brandt T, Berta-Thompson Z, Lewandowsha N, Knierman K, Chanover N, Whitley J, Venkatesan A, Coble K, Burgasser A, Lemoine-Busserolle M, Cruz K, Moore CS, Osei-Sarfo K, and Kannappan S. Astro 2020 APC White Paper: Tying research funding to progress on inclusion. Astro2020 Decadal Survey. 2019: arXiv:1907.13202v1

  • Urvalek AM, Osei-Sarfo K, Tang XH, Scognamiglio T, Zhang T, and Gudas LJ. Identification of ethanol and 4-nitroquinoline-1-oxide induced epigenetic and oxidative stress markers during oral cavity carcinogenesis. Alcoholism: Clinical and Experimental Research. 2015; 39(8): 1360-1372.

  • Tang XH, Osei-Sarfo K, Urvalek AM, Scognamiglio T, Gudas LJ. (2014). Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline-1-oxide. PNAS. 2014; 111(24): 8907-8912.

PATENT:

  • U.S. Patent 20200179317A1, “Combination therapy for head and neck cancer”, Mar. 09, 2015.